ISPOR Launches Expanded HEOR Presentations Database

New Presentations Database Offers a Comprehensive, Searchable Resource

Lawrenceville, NJ, USA—July 9, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), launched an expanded, enhanced HEOR resource—the ISPOR Presentations Database.

Read more ›
Posted in Announcements, ISPOR News & Press

Healthcare Experts Debate New Methods of Assessing the Value of Prescription Drugs, Medical Devices, and Procedures

Value in Health Supplement Reports Findings of Third Annual ISPOR Summit

Lawrenceville, NJ, USA—June 18, 2019—Value in Health, the official journal of ISPOR, the professional society for health economics and outcomes research, announced today the publication of a new supplement, “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare.” The 6 articles included in this supplement are based on presentations from the Third Annual ISPOR Summit held in Washington, DC, USA on October 19, 2018. Full text of the articles is freely available online and the supplement will be indexed in MEDLINE®/PubMed. The supplement, which was published in June 2019 along with the regular issue of Value in Health, extends the reach and expands access to important discussions about how healthcare stakeholders in the United States are assessing value in healthcare today and into the future.

Read more ›
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , ,

A Beginner’s Guide to Understanding Curative Therapies

Value in Health, September 2019

Value in Health Themed Section Offers Updated Perspective

Lawrenceville, NJ, USA—June 17, 2019—Value in Health, the official journal of ISPOR, the professional society for health economics and outcomes research, announced today the publication of a series of articles offering important insight regarding the current state of curative and transformative therapies. The special themed section appears in the June 2019 issue of Value in Health. Guest editors for the themed section are Don Husereau, BSc Pharm, MSc, University of Ottawa, Ottawa, ON, Canada, and Shelby D. Reed, RPh, PhD, Duke University, Durham, NC, USA.

Read more ›
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR Board of Directors Approves New Diversity and Inclusion Policy

Lawrenceville, NJ, USA—June 11, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced the approval of the Society’s new Diversity and Inclusion Policy.

Read more ›
Posted in Announcements, ISPOR News & Press, Uncategorized Tagged with: , , ,

ISPOR Announces 2019-2020 Board of Directors

Nancy J. Devlin, PhD Moves Into the Role of President

Lawrenceville, NJ, USA—June 10, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced the results of its recent elections and its 2019-2020 Board of Directors. The Society’s membership selects its new president-elect and the 2019-2020 board will assume office on July 1, 2019.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with:

ISPOR 2019 Convened Nearly 4000 Healthcare Stakeholders

Conference Focused on the Future of HEOR

New Orleans, LA, USA—May 23, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), recently concluded its ISPOR 2019 annual conference in New Orleans, LA, USA. The conference convened nearly 4000 healthcare stakeholders representing more than 65 countries and from all sectors of healthcare, including policy makers, global thought leaders, researchers and academicians, public and private payers, healthcare providers, and patient engagement organizations. The conference centered on the timely theme, “Rapid. Disruptive. Innovative. A New Era in HEOR,” and addressed a wide variety of compelling topics in HEOR.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with:

ISPOR Wins Multiple Hermes Creative Awards

The Society Was Recognized for Its Rebranding Campaign, Website Redesign, and “Top 10 HEOR Trends” Horizon Scanning Report

Lawrenceville, NJ, USA—May 23, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR)—has won 6 Platinum and Gold level Hermes Awards for its rebranding campaign, website redesign, and “2019 Top 10 HEOR Trends” report.

Read more ›
Posted in Announcements, ISPOR News & Press, Uncategorized Tagged with: , ,

Patient Access and Biosimilars

New Orleans, LA, USA—May 22, 2019ISPOR the professional society for health economics and outcomes research (HEOR), examined the issue of patient access and biosimilars this afternoon at its ISPOR 2019 annual conference with the session [W20], “Improving Patient Access to Life Saving Therapies: What Needs to Be Done to Fulfill the Promise of Biosimilars?”

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: ,

Is Healthcare Affordability Driving a Need to Revolutionize Drug Pricing?

The Explosion of Innovative, New Therapies and Payers’ Crisis of Affordability

New Orleans, LA, USA—May 22, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), held its final plenary of the ISPOR 2019 annual conference with, “Is Healthcare Affordability Driving a Need to Revolutionize Drug Pricing?”

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: , ,

High Healthcare Costs in the United States—Could Formal Health Technology Assessment Be a Solution?

New Orleans, LA, USA—May 22, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), explored the possibility of health technology assessment (HTA) in the United States this morning at its ISPOR 2019 annual conference with the session [IP26], “Could Formal HTA Be a Solution to High Healthcare Costs in the United States?”

The United States has the highest healthcare costs per person in the world. HTA is often seen as a method for drug cost control; however, the US healthcare system lacks a national HTA body with a formal mandate and binding authority. A number of differences in the US healthcare system complicate the issue, such as reimbursement structures, stakeholder incentives, and a pluralistic payer system. The United States’ notable absence of an HTA body contrasts markedly with other countries where healthcare is more affordable. The increase in the number of institutions in the United States that are developing value frameworks for assessment of therapies could signal a greater willingness to accept formal HTA as part of reimbursement.

Panelists for the session included:

  • Wrik Ghosh, MSc; Costello Medical Singapore Pte Ltd; Singapore
  • Sarah Breen, MA, MSc; MSD UK; Hoddesdon, England, UK
  • Thomas Butt, PhD; Peking University; Beijing, China
  • Daniel A. Ollendorf, PhD; Tufts Medical Center; Boston, MA, USA

Dr Ollendorf provided an HTA perspective, comparing the efforts made by the Institute for Clinical and Economic Review (ICER) in the United States to those abroad, highlighting feasible options. Dr Butt offered an international perspective, discussing whether the United States can learn from countries that have successfully implemented HTA or whether there are higher priorities for US healthcare system. Ms Breen offered a manufacturer perspective, noting that formal HTA could present a threat to manufacturers’ profits and change incentives, but could also provide opportunities to demonstrate value and improve patient access.

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and its role in improving healthcare decisions. ISPOR 2019 is the leading global HEOR conference and draws nearly 4000 healthcare thought leaders and stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information | Program | Registration | Short Course Program | Sponsors | Exhibitors | Press

###

ABOUT ISPOR

ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,